ES2076378T3 - Metodo para la inhibicion del desarrollo de celulas de tallo. - Google Patents

Metodo para la inhibicion del desarrollo de celulas de tallo.

Info

Publication number
ES2076378T3
ES2076378T3 ES90916178T ES90916178T ES2076378T3 ES 2076378 T3 ES2076378 T3 ES 2076378T3 ES 90916178 T ES90916178 T ES 90916178T ES 90916178 T ES90916178 T ES 90916178T ES 2076378 T3 ES2076378 T3 ES 2076378T3
Authority
ES
Spain
Prior art keywords
stem cells
inhibition
development
agents
cycling
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90916178T
Other languages
English (en)
Other versions
ES2076378T5 (es
Inventor
Ian B Pragnell
Debra D Donaldson
Gerald J Graham
Gordon G Wong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CRC Technology Ltd
Genetics Institute LLC
Original Assignee
CRC Technology Ltd
Genetics Institute LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27021719&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2076378(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by CRC Technology Ltd, Genetics Institute LLC filed Critical CRC Technology Ltd
Publication of ES2076378T3 publication Critical patent/ES2076378T3/es
Application granted granted Critical
Publication of ES2076378T5 publication Critical patent/ES2076378T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

LA PRESENTE INVENCION PRESENTA UN METODO PARA PROTEGER EL CICLO O DIVISION DE CELULAS VEGETALES DE LOS EFECTOS CITOTOXICOS DE AGENTES QUIMIOTERAPEUTICOS Y DE LA RADIACION A BASE DE ADMINISTRAR, ANTES DE LA EXPOSICION A ESTOS AGENTES, UNA CANTIDAD EFECTIVA DE UN FACTOR INHIBIDOR DE CELULAS VEGETALES ASI COMO UNA COMPOSICION UTIL PARA ELLO.
ES90916178T 1989-09-25 1990-09-25 Metodo para la inhibicion del desarrollo de celulas de tallo. Expired - Lifetime ES2076378T5 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41230389A 1989-09-25 1989-09-25
US58171390A 1990-09-13 1990-09-13

Publications (2)

Publication Number Publication Date
ES2076378T3 true ES2076378T3 (es) 1995-11-01
ES2076378T5 ES2076378T5 (es) 1999-10-16

Family

ID=27021719

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90916178T Expired - Lifetime ES2076378T5 (es) 1989-09-25 1990-09-25 Metodo para la inhibicion del desarrollo de celulas de tallo.

Country Status (10)

Country Link
US (1) US5674841A (es)
EP (1) EP0494268B2 (es)
JP (1) JPH05502443A (es)
AT (1) ATE124421T1 (es)
CA (1) CA2064558C (es)
DE (1) DE69020573T3 (es)
DK (1) DK0494268T4 (es)
ES (1) ES2076378T5 (es)
MX (1) MX9203438A (es)
WO (1) WO1991004274A1 (es)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2091266A1 (en) * 1990-09-14 1992-03-15 Patricia Tekamp-Olson Expression of macrophage inducible proteins (mips) in yeast cells
JPH07502404A (ja) * 1991-12-23 1995-03-16 ブリティッシュ　バイオ−テクノロジー　リミテッド 幹細胞阻害タンパク質
FR2691153B1 (fr) * 1992-05-18 1995-06-30 Serbio Dodecapeptides monomere et dimere, utilisation en tant qu'agents anti-megacaryocytaires.
US5939391A (en) * 1993-03-31 1999-08-17 Pro-Neuron, Inc. Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation
ATE225370T1 (de) * 1993-03-31 2002-10-15 Pro Neuron Inc Inhibitor der stammzellproliferation und seine verwendung
US6610654B2 (en) 1993-03-31 2003-08-26 Wellstat Therapeutics Corporation Inhibitor of stem cell proliferation and uses thereof
GB9308060D0 (en) * 1993-04-19 1993-06-02 Cancer Res Campaign Tech Stem cell inhibitor
DE69430059T2 (de) * 1993-06-15 2002-11-14 British Biotech Pharmaceuticals Ltd., Cowley Freisetzung und Mobilisierung hämatopoietischer Zellen
US6001606A (en) * 1994-03-08 1999-12-14 Human Genome Sciences, Inc. Polynucleotides encoding myeloid progenitor inhibitory factor-1 (MPIF-1) and polypeptides encoded thereby
US6811773B1 (en) 1993-12-22 2004-11-02 Human Genome Sciences, Inc. Human monocyte colony inhibitory factor (M-CIF) polypeptides
US6488925B2 (en) 1993-12-22 2002-12-03 Human Genome Sciences, Inc. Macrophage inflammatory protein-4 (MIP-4) polypeptides
US6623942B2 (en) 1994-03-08 2003-09-23 Human Genome Sciences, Inc. Macrophage inflammatory protein-4 (MIP-4) polynucleotides
US6495129B1 (en) 1994-03-08 2002-12-17 Human Genome Sciences, Inc. Methods of inhibiting hematopoietic stem cells using human myeloid progenitor inhibitory factor-1 (MPIF-1) (Ckbeta-8/MIP-3)
ATE216425T1 (de) * 1994-08-13 2002-05-15 Roche Diagnostics Gmbh Verwendung von interferon-gamma zur vermeidung der proliferation und differenzierung der primitiven hämapoietischen vorläuferzellen
EP0696639B1 (en) * 1994-08-13 2002-04-17 Boehringer Mannheim Gmbh Use of interferon gamma for the inhibition of proliferation and differentiation of primitive hematopoietic progenitor cells
US6391589B1 (en) 1994-08-23 2002-05-21 Human Genome Sciences, Inc. Human chemokine beta-10 mutant polypeptides
US6174995B1 (en) 1994-08-23 2001-01-16 Haodong Li Human chemokines, CKβ4 and CKβ10/MCP-4
US6458349B1 (en) 1995-06-02 2002-10-01 Human Genome Sciences, Inc. Chemokine β-4 polypeptides
US5981230A (en) * 1994-08-23 1999-11-09 Human Genome Sciences, Inc. Polynucleotide encoding chemokine β-4
US6139832A (en) 1995-02-08 2000-10-31 Human Genome Sciences, Inc. Leukocyte adhesion inhibitor-1 (LAI-1) Polypeptides
US6040431A (en) * 1995-06-07 2000-03-21 Stryker Corporation Single chain analogs of the TGF-β superfamily (morphons)
ZA97990B (en) * 1996-02-09 1997-08-06 Schering Corp Mammalian dendritic cell chemokine reagents.
US6410268B1 (en) 1996-03-18 2002-06-25 Human Genome Sciences, Inc. Polynucleotides encoding chemokine alpha-3
JP2000507101A (ja) * 1996-03-19 2000-06-13 ヒューマン・ジェノム・サイエンシズ・インコーポレイテッド ケモカインアルファ２
US5861483A (en) 1996-04-03 1999-01-19 Pro-Neuron, Inc. Inhibitor of stem cell proliferation and uses thereof
US6290948B1 (en) 1996-05-14 2001-09-18 Smithkline Beecham Corporation Method of treating sepsis and ARDS using chamohine beta-10
CA2305787A1 (en) 2000-05-09 2001-11-09 The University Of British Columbia Cxcr4 antagonist treatment of hematopoietic cells
CA2245224A1 (en) 1998-08-14 2000-02-14 Jiang-Hong Giong Chemokine receptor antagonists and chemotherapeutics
DE69914463T2 (de) 1998-03-13 2004-11-11 The University Of British Columbia, Vancouver Therapeutische chemokine rezeptor antagonisten
US7097832B1 (en) 1999-03-30 2006-08-29 Myocardial Therapeutics, Inc. Intramyocardial injection of autologous bone marrow
DK1171165T3 (da) * 1999-03-30 2007-09-03 Ran Kornowski Injektion af autolog knoglemarv i myokardiet
US7378098B2 (en) 2000-04-12 2008-05-27 The University Of British Columbia CXC chemokine receptor 4 agonist peptides
US7368425B2 (en) 2006-03-24 2008-05-06 Chemokine Therapeutics Corp. Cyclic peptides for modulating growth of neo-vessels and their use in therapeutic angiogenesis
CA2335109A1 (en) * 2000-04-12 2001-10-12 Chemokine Therapeutics Corporation Cxcr4 agonist treatment of hematopoietic cells
US20050059584A1 (en) 2002-08-16 2005-03-17 Ahmed Merzouk Novel chemokine mimetics synthesis and their use
US7045353B2 (en) 2000-08-01 2006-05-16 Yissum Research Development Company Of The Hebrew University Of Jerusalem Directed differentiation of human embryonic cells
EP1534752B1 (en) 2002-05-01 2011-08-03 Human Genome Sciences, Inc. Antibodies that specifically bind to chemokine beta-4
US8921315B1 (en) * 2008-04-24 2014-12-30 Neumedicines, Inc. Method of increasing survival of a human subject having exposure to an acute exposure to non-therapeutic whole body ionization by administering a therapeutically effective dose of IL-12
EP2640744A4 (en) 2010-11-19 2014-05-28 Eisai R&D Man Co Ltd NEUTRALIZATION OF ANTIBODIES TO CCL20

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4822776A (en) * 1981-09-08 1989-04-18 The Rockefeller University Lipoprotein lipase suppression by endotoxin-induced mediator (shock assay)
IE60950B1 (en) * 1987-09-28 1994-09-07 Beecham Inc Inactivation of viruses and bacteria
US5041289A (en) * 1987-11-13 1991-08-20 Becton Dickinson And Company Method of purging residual tumor cells in vitro with lymphokine activated cytotoxic cells
JPH04500970A (ja) * 1988-09-02 1992-02-20 ザ ロックフェラー ユニヴァーシティ マクロファージ由来炎症メディエーター　（ｍｉｐ―２）
WO1991000103A1 (en) * 1989-06-29 1991-01-10 The United States Of America, Represented By The Secretary, United States Department Of Commerce Method for protecting bone marrow against chemotherapeutic drugs and radiation therapy using transforming growth factor beta 1

Also Published As

Publication number Publication date
EP0494268B2 (en) 1999-04-28
ATE124421T1 (de) 1995-07-15
CA2064558C (en) 2001-01-30
EP0494268A1 (en) 1992-07-15
WO1991004274A1 (en) 1991-04-04
DK0494268T4 (da) 1999-11-08
DE69020573D1 (de) 1995-08-03
DK0494268T3 (da) 1995-08-28
EP0494268B1 (en) 1995-06-28
CA2064558A1 (en) 1991-03-26
ES2076378T5 (es) 1999-10-16
MX9203438A (es) 1992-07-01
JPH05502443A (ja) 1993-04-28
US5674841A (en) 1997-10-07
DE69020573T3 (de) 1999-12-16
DE69020573T2 (de) 1995-11-30

Similar Documents

Publication Publication Date Title
ES2076378T3 (es) Metodo para la inhibicion del desarrollo de celulas de tallo.
BR9815340A (pt) Utilização de pelo menos um ativador dos receptores de tipo ppar-y.
IT1164634B (it) Derivati cefalosporinici e composizioni antibatteriche che li contengono,nonche' procedimento per la loro produzione
ES472641A1 (es) Procedimiento para la obtencion de propenil-aminas
IT8049060A0 (it) Procedimento per la polimerizzazio ne per irradiazione di composizioni di poliacrilati
IT8422785A0 (it) Derivati del benzossazolone e delbenzotiazolone, procedimenti per la loro preparazione e composizione farmaceutica che li contiene.
ES275579Y (es) Juego de celdas para el crecimiento de plantas
IT8123940A0 (it) Derivati della s-adenosilmetionina, processo per la loro preparazione e composizioni terapeutiche che licontengono come principio attivo.
MY100900A (en) Substituted phenylsulfonyloxybenzimidazolecarbamates, processes for their preparation and their use as medicaments.
IT8424283A0 (it) Uso di derivati del tiofene nel trattamento dei tumori, composizioni farmaceutiche che licontengono e composti atti allo scopo.
BR8108410A (pt) Composicao para o condicionamento de plantas,contendo titanio
JPS5271253A (en) Compound lens of high resolving power
ES477562A1 (es) Procedimiento para preparar derivados de alcanolamina.
ES479059A1 (es) Procedimiento para preparar derivados del naftaleno.
IT8522359A0 (it) Composizioni farmaceutiche che li derivati di vitamina d,contengono e loro precursori.
MXPA99009874A (es) Nuevos derivados de amidina.
IT8522868A0 (it) Derivati tienopiridinici, procedimento per la loro preparazione e composizioni terapeutiche che li contengono.
FR2454803A1 (fr) Composition amincissante et procede d'utilisation de celle-ci
BG38936A3 (en) Means for protection from helminths
IT8109326A0 (it) Derivati del benzossazolone,procedimenti per la preparazione di questi e composizioni che li contengono
FR2392966A1 (fr) Nouveaux acides uree-bis(naphtalene-sulfoniques et naphtalene-carboxyliques), leurs sels pharmaceutiquement acceptables, et leur utilisation therapeutique
ES8800171A1 (es) Procedimiento de obtencion de nuevos derivados nitrogenados penta o hexa ciclicos sustituidos por un radical aminado
IT8023631A0 (it) Derivati di nitroalcanol,procedimento per produrli e composizioni di protezione per piante che li contengono.
JPS5378248A (en) Method of preventing yellowing of polyolefin composition
BR7808242A (pt) Composto,processo para regulacao do crescimento de plantas leguminosas,e composicao reguladora do crescimento de plantas

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 494268

Country of ref document: ES